Cancer Profiling Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Cancer Profiling Market is Segmented by Technology (Immunoassays, Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, and Others), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), Biomarker Type (Genetic Biomarkers, Protein Biomarkers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Cancer Profiling Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Cancer Profiling Industry Overview

The market for cancer profiling is fragmented, with several major players operating in the market. The factors owing to the competition include the rising launch of innovative cancer profiling products and rising investments in cancer genomics by companies, among others. Some companies currently operating in the market are Illumina, Inc., QIAGEN, Sysmex Corporation, NeoGenomics Laboratories, and HTG Molecular Diagnostics, Inc., among others.

Cancer Profiling Market Leaders

  1. Illumina, Inc

  2. QIAGEN

  3. Sysmex Corporation

  4. NeoGenomics Laboratories

  5. HTG Molecular Diagnostics, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Cancer Profiling Market Concentration

Cancer Profiling Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?